Chain of Title – The Importance of Getting It Right

Published April 2020

Chain of Title – The Importance of Getting It Right

Making sure there are no issues with ownership of IP is of crucial importance to any business. The current economic outlook is likely to result in events which require careful management of IP.

Insolvency situations where IP is transferred as a valuable asset, litigation, where businesses try and protect their product and IP rights and sales of IP to raise funds are likely to be more and more common.

In our experience many companies suffer from broken links in the chain of ownership of their IP. Unless ownership of IP has been carefully managed, the problems facing businesses in such events could be costly, and at worse, fatal for a business.

In addition, mistakes often occur when IP rights are transferred as part of a bankruptcy or restructuring situation either because a) proper investigation into the subsistence and ownership of rights has not taken place before the transfer or  b) the rights are not transferred correctly to the new owner

What can go wrong?

Among many other things, the following problems can arise;

  • If a business sale agreement does not contain adequate wording to transfer the IP or there is no follow up assignment, a business purchasing that asset may find themselves having paid for an IP right they don’t actually own. If the previous owner is no longer in existence this can be a difficult situation to remedy.
  • A company who does not own an IP right will not be able to licence, transfer or enforce the right against third parties.  The IP may be an important part of the assets of a company but may not in fact be correctly owned by the company.
  • Where chain of title for a patent or other IP right is not correct, a business may lose  the right to file subsequent applications for the same invention, trade mark or registered design in another jurisdiction.
  • Bad management of records / previous transfers can cause major issues when looking to transfer or licence IP in a short time period.
How Can A Business Address this?
  • Ensuring that on any due diligence a careful review of all IP rights owned by a business is carried out and that the chain of title to these rights is correct. For example – ensuring that any consultants who have carried out work, have transferred such rights to a business, or inventors have transferred their rights in any inventions or that previous transfers are valid
  • Ensuring that where deficiencies occur, that assignments or other remedy to correct title of those rights are carried out
  • Careful document drafting /  management – ensuring that all assignments of IP rights are in the correct form, signed correctly, recorded at the relevant IP office and that the documents are stored in places that are easily accessible. Having documents in hard copy format during the Covid-19 Pandemic could make them difficult to access, so ensuring that where assignments have been executed that electronic copies are available is a good idea.
  • Making sure all transfer documents are reviewed properly to ensure that they are effective in transferring the rights that are intended.

This update was prepared by HGF Senior IP Solicitor Chris Robinson. If you would like further advice on this or any other matter, please contact Chris.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details
Event - 15th December 2026

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Event details
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article
Event - 28th October 2026

HGF Attending the KINPA Conference 2026

HGF is pleased to be attending the KINPA Conference 2026, taking place on 28 October in Seoul, South Korea. Recognised as Korea’s largest intellectual property gathering, the conference brings together …

Event details
Event - 17th - 19th November 2026

HGF Attending IPBC Asia 2026

HGF is pleased to announce that Partner, Dr Jennifer Uno, will be attending IPBC Asia 2026, taking place from 17-19 November 2026 in Tokyo, Japan. The event is one of …

Event details

HGF Recognised in the Chambers and Partners UK 2027 Guide

HGF is proud to announce that we have once again been recognised in the Chambers and Partners UK 2027 Guide, with outstanding rankings for both the firm and individual practitioners …

Read article
Event - 4th November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Event details